Eyenovia, Inc. (NASDAQ:EYEN) Director Ellen R. Strahlman Buys 10,000 Shares

Eyenovia, Inc. (NASDAQ:EYEN – Get Rating) Director Ellen R. Strahlman bought 10,000 shares of the company’s stock in a transaction on Tuesday, May 23rd. The stock was bought at an average cost of $3.10 per share, for a total transaction of $31,000.00. Following the completion of the transaction, the director now directly owns 53,052 shares of the company’s stock, valued at $164,461.20. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Eyenovia Price Performance

Shares of NASDAQ EYEN opened at $2.52 on Friday. Eyenovia, Inc. has a 1-year low of $1.50 and a 1-year high of $5.85. The company has a quick ratio of 5.09, a current ratio of 5.09 and a debt-to-equity ratio of 0.47. The business’s fifty day moving average price is $3.91 and its two-hundred day moving average price is $2.80.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $12.00 target price on shares of Eyenovia in a research report on Wednesday, April 19th.

Institutional Investors Weigh In On Eyenovia

Several large investors have recently added to or reduced their stakes in the stock. Palisade Capital Management LP acquired a new stake in Eyenovia in the fourth quarter worth $513,000. Palisade Capital Management LLC NJ acquired a new position in shares of Eyenovia during the fourth quarter valued at $513,000. Renaissance Technologies LLC increased its holdings in shares of Eyenovia by 9.2% during the fourth quarter. Renaissance Technologies LLC now owns 288,500 shares of the company’s stock valued at $470,000 after purchasing an additional 24,400 shares during the period. Geode Capital Management LLC increased its holdings in shares of Eyenovia by 2.4% during the fourth quarter. Geode Capital Management LLC now owns 260,067 shares of the company’s stock valued at $423,000 after purchasing an additional 6,056 shares during the period. Finally, Millennium Management LLC increased its holdings in shares of Eyenovia by 27.0% during the second quarter. Millennium Management LLC now owns 112,654 shares of the company’s stock valued at $220,000 after purchasing an additional 23,950 shares during the period. 6.23% of the stock is owned by institutional investors and hedge funds.

About Eyenovia

(Get Rating)

Eyenovia, Inc is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine.